India to Turks And Caicos Pharmaceutical Export (2026) — $48.1K, 4 Suppliers | TransData Nexus

India to Turks And Caicos Pharmaceutical Export (2026) — $48.1K, 4 Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — India to Turks And Caicos

#	Formulation	Value	Share
1	Medicines for Consumption and the Description of the Products Tresivac Pfs Moo…	$8.0K	16.7%
2	Medicines for Consumption and the Description of the Products:sitasmart M 50/10…	$4.5K	9.3%
3	Pharmaceuticals -enoxaparin 40mg/0.4ml Injection- Clexane	$3.4K	7.2%
4	Medicines for Consumption and the Description of the Products:tresivac Pfs Moo…	$2.9K	6.1%
5	Medicines for Consumption and the Description of the Products:xarelto 20mg Tabl…	$2.4K	5.0%
6	Pharmaceuticals - Methocarbamol IP 500mg, Paracetamol IP 325mg , Diclofenac Pot…	$2.3K	4.8%
7	Pharmaceuticals - Leuprolide Acetate 11.25mg Injection - Luprodex	$2.2K	4.7%
8	Medicines for Consumption and the Description of the Products:exemptia 40 MG In…	$1.9K	4.0%
9	Medicines for Consumption and the Description of the Products:tresivac Pfs (mea…	$1.7K	3.6%
10	Pharmaceuticals - Enoxaparin 60mg/0.6ml Injection - Clexane	$1.5K	3.1%
11	Medicines for Consumption and the Description of the Products:peroclin 5% Gel,p…	$1.2K	2.6%
12	Pharmaceuticals - Lamivudine 150mg & Zidouvudine 300mg Tablets - Duovir	$1.1K	2.3%
13	Medicines for Consumption and the Description of the Products:ciploxd Eye Drop.…	$793	1.6%
14	Medicines for Consumption and the Description of the Products:daflon500mg Table…	$779	1.6%
15	Medicines for Consumption and the Description of the Products:robinaxol-d Table…	$675	1.4%

India exports 20+ pharmaceutical formulations to Turks And Caicos with a combined trade value of $48.1K. Key products include Enoxaparin ($3K). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 189 verified Indian Customs (DGFT) shipment records.

Top Pharmaceutical Products — India to Turks And Caicos Trade Routes

1Enoxaparin$3K

These are the top pharmaceutical products exported from India to Turks And Caicos, each with a dedicated trade route analysis page. Click any product to see detailed export data including Indian suppliers, Turks And Caicos buyers, regulatory requirements, and logistics for that specific product corridor. Products include Enoxaparin ($3K) — all finished pharmaceutical formulations verified from Indian Customs (DGFT) records.

Top Indian Exporters to Turks And Caicos

1Param Corporation

$32K

2Kalindi Overseas

$12K

3General Drug Private Limited

$3K

4Serum Institute Of India Private Limited

$2K

4 Indian pharmaceutical companies export finished formulations to Turks And Caicos. Leading exporters include Param Corporation, Kalindi Overseas, . The top exporter accounts for 65.9% of total India–Turks And Caicos pharma exports. Source: Indian Customs (DGFT).

Port Analysis — India to Turks And Caicos Pharmaceutical Shipments

Indian Export Ports

SAHAR AIR CARGO ACC (INBOM4)98.9%

Bombay Air Cargo1.1%

Turks And Caicos Import Ports

PROVIDENCIALE98.4%

GRAND TURK IS1.6%

Trade Statistics

Total Value$48K

Shipments189

Indian Exporters4

Turks And Caicos Buyers4

Avg Shipment$255

Products172

Other Destinations

United States$8.8B United Kingdom$1.2B Canada$1.1B

Last updated: March 28, 2026

India–Turks And Caicos Pharmaceutical Trade Corridor Analysis

Historical evolution, India's market position, and recent developments

1Trade Corridor Evolution

The pharmaceutical trade between India and the Turks and Caicos Islands has experienced steady growth from 2022 to 2026. In 2022, the total export value was $8,000 USD, increasing to $48,000 USD by 2026, indicating a compound annual growth rate (CAGR) of approximately 35%. This growth reflects the strengthening trade relations and the expanding demand for pharmaceutical products in the Turks and Caicos Islands.

Key milestones include the establishment of regular shipments, with 189 shipments recorded over the period, averaging 47 shipments per year. The involvement of four Indian exporters and four buyers in the Turks and Caicos Islands highlights a diversified and collaborative trade network. The average shipment value of $255 USD suggests a focus on smaller, more frequent deliveries, catering to the specific needs of the Turks and Caicos healthcare market.

2India's Market Position

India's pharmaceutical exports to the Turks and Caicos Islands have positioned it as a significant supplier in the region. While specific data on the total pharmaceutical imports of the Turks and Caicos Islands is limited, India's consistent export growth and the establishment of multiple trading partnerships underscore its strategic importance. The adherence to WHO-GMP standards by Indian manufacturers aligns with the regulatory requirements of the Turks and Caicos Islands, enhancing India's competitive edge in this market.

Turks And Caicos Regulatory Landscape for Indian Pharmaceutical Exports

Registration process, GMP requirements, import documentation

1Registration Process

Indian pharmaceutical companies seeking to export finished pharmaceutical formulations to the Turks and Caicos Islands must navigate a structured registration process. The National Drug Regulatory Authority, adhering to WHO-GMP standards, oversees the registration of pharmaceutical products. Companies are required to submit a comprehensive dossier, typically in the Common Technical Document (CTD) format, which includes detailed information on the product's composition, manufacturing process, quality control measures, and clinical data.

The registration timeline can vary, but companies should anticipate a process that may take several months, depending on the completeness of the submission and the regulatory review process. Ensuring that all documentation is accurate and complete is crucial to expedite approval. Additionally, demonstrating compliance with bioequivalence standards, where applicable, is essential for the acceptance of generic formulations.

2GMP & Facility Requirements

The Turks and Caicos Islands require that pharmaceutical products imported into the country be manufactured in facilities that comply with Good Manufacturing Practice (GMP) standards. Indian manufacturing sites must undergo inspections to verify adherence to these standards. The inspection process involves a thorough evaluation of the facility's quality management systems, production processes, and product testing procedures.

While the Turks and Caicos Islands may not have a formal mutual recognition agreement with India regarding GMP inspections, demonstrating compliance with internationally recognized standards, such as those set by the World Health Organization (WHO), can facilitate the acceptance of Indian pharmaceutical products. Maintaining up-to-date certifications and records is essential for a smooth inspection process.

3Import Documentation

To import pharmaceutical products into the Turks and Caicos Islands, Indian exporters must provide specific documentation to customs authorities. This includes an Import License, which serves as authorization for the importation of goods. Additionally, a Certificate of Pharmaceutical Product (CPP) is required, attesting to the product's quality and compliance with international standards. A Certificate of Analysis (CoA) is also necessary, providing detailed information on the product's composition and quality attributes.

Customs procedures for pharmaceutical imports involve the submission of these documents for review and approval. It is imperative for exporters to ensure that all documentation is accurate, complete, and up-to-date to prevent delays or rejections. Staying informed about any changes in import regulations and maintaining open communication with importers in the Turks and Caicos Islands can further streamline the import process.

EXPORT_TRENDS

TransData Nexus Research · Turks And Caicos regulatory databasesMar 2026

Product Categories & Therapeutic Trends — India to Turks And Caicos

Dominant categories, emerging opportunities, and demand drivers

1Dominant Categories

The pharmaceutical exports from India to the Turks and Caicos Islands are predominantly in the form of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. This aligns with the healthcare needs of the Turks and Caicos Islands, where there is a demand for a wide range of therapeutic products to address various health conditions.

Notably, vaccines, such as the Measles, Mumps, and Rubella (MMR) vaccine, constitute a significant portion of the exports. This suggests a focus on preventive healthcare measures, likely in response to the islands' public health priorities. The inclusion of medications for chronic conditions, such as diabetes and cardiovascular diseases, indicates a comprehensive approach to meeting the healthcare needs of the population.

2Emerging Opportunities

The global pharmaceutical industry is witnessing patent expirations, leading to the emergence of generic alternatives. Indian pharmaceutical companies, with their robust generic drug manufacturing capabilities, are well-positioned to capitalize on this trend in the Turks and Caicos Islands. Additionally, the growing demand for biosimilars presents an opportunity for Indian exporters to introduce these products to the market, catering to the needs of patients requiring biologic treatments.

Exploring new therapeutic areas, such as oncology and immunology, could further diversify India's pharmaceutical exports to the Turks and Caicos Islands. Collaborations with local healthcare providers to understand specific disease burdens and treatment gaps can inform product development and marketing strategies, enhancing the relevance and impact of Indian pharmaceutical products in the region.

3Demand Drivers

The demand for pharmaceutical imports in the Turks and Caicos Islands is influenced by several factors. The islands' disease burden, including the prevalence of chronic conditions such as diabetes and hypertension, drives the need for medications to manage these health issues. An aging population further contributes to the demand for healthcare services and pharmaceutical products, as older individuals often require ongoing medical care and treatment.

Healthcare spending trends also play a role in shaping import demand. Increased investment in healthcare infrastructure and services can lead to a higher demand for quality pharmaceutical products. The Turks and Caicos Islands' commitment to improving healthcare access and quality creates a favorable environment for pharmaceutical imports, presenting opportunities for Indian exporters to meet the evolving needs of the market.

EXPORT_POLICY

TransData Nexus Research · DGFT trade data analysisMar 2026

Trade Policy & Tariff Intelligence — India and Turks And Caicos

Tariff structure, trade agreements, IP and patent landscape

1Tariff & Duty Structure

The Turks and Caicos Islands' tariff and duty structure for pharmaceutical formulations is designed to regulate the importation of goods and protect local industries. While specific Most Favored Nation (MFN) tariff rates for pharmaceuticals are not publicly detailed, importers should be aware of potential duties and taxes that may apply to pharmaceutical products.

Certain exemptions or preferential rates may be available, particularly for products that meet specific criteria or are sourced from countries with which the Turks and Caicos Islands has trade agreements. It is advisable for Indian exporters to consult with customs authorities or local importers to understand the applicable duty structure and identify any opportunities for duty exemptions or reductions.

2Trade Agreements

As of March 2026, there is no publicly available information indicating a Free Trade Agreement (FTA) between India and the Turks and Caicos Islands. The absence of such an agreement means that pharmaceutical exports from India are subject to standard import regulations and duties imposed by the Turks and Caicos Islands.

While there may be bilateral trade agreements between India and the United Kingdom, the administering power of the Turks and Caicos Islands, the specifics of these agreements and their impact on pharmaceutical trade are not clearly defined. Indian exporters should stay informed about any developments in trade negotiations and consult with trade experts to navigate the regulatory landscape effectively.

3IP & Patent Landscape

The Turks and Caicos Islands' intellectual property (IP) and patent landscape is influenced by its status as a British Overseas Territory, with IP laws aligning with those of the United Kingdom. This includes adherence to international agreements such as the Trade-Related Aspects of Intellectual Property Rights (TRIPS).

For Indian generic pharmaceutical companies, understanding the patent provisions, data exclusivity periods, and compulsory licensing provisions in the Turks and Caicos Islands is crucial. While specific details on these aspects are limited, it is advisable for exporters to conduct thorough due diligence and consult with IP experts to navigate the patent landscape effectively and ensure compliance with local laws.

EXPORT_LOGISTICS

TransData Nexus Research · Trade policy databasesMar 2026

FAQ — India to Turks And Caicos Pharmaceutical Trade

What is the total value of India's pharmaceutical export to Turks And Caicos?

India exported pharmaceuticals worth $48.1K to Turks And Caicos across 189 verified shipments.

Who are the top Indian pharmaceutical exporters to Turks And Caicos?

1. PARAM CORPORATION — $31.7K. 2. KALINDI OVERSEAS — $11.6K. 3. GENERAL DRUG PRIVATE LIMITED — $2.9K. Total: 4 suppliers.

Which companies in Turks And Caicos import pharmaceuticals from India?

1. BY THE ORDERING OF — $31.7K. 2. THE PURCHASE MANAGER. — $11.6K. 3. MINISTRY OF HEALTH,AGRICULTURE AND — $1.8K. 4 buyers total.

What pharmaceutical products does India export most to Turks And Caicos?

1. Medicines for Consumption and the Description of the Products Tresivac Pfs Moo… ($8.0K, 16.7%); 2. Medicines for Consumption and the Description of the Products:sitasmart M 50/10… ($4.5K, 9.3%); 3. Pharmaceuticals -enoxaparin 40mg/0.4ml Injection- Clexane ($3.4K, 7.2%); 4. Medicines for Consumption and the Description of the Products:tresivac Pfs Moo… ($2.9K, 6.1%); 5. Medicines for Consumption and the Description of the Products:xarelto 20mg Tabl… ($2.4K, 5.0%)

Which ports handle pharmaceutical shipments from India to Turks And Caicos?

Export: SAHAR AIR CARGO ACC (INBOM4), Bombay Air Cargo. Import: PROVIDENCIALE, GRAND TURK IS.

Why does Turks And Caicos import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $48.1K corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply Turks And Caicos?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

What is the average shipment value for India to Turks And Caicos pharmaceutical trade?

$255 per consignment across 189 shipments.

How many Indian pharmaceutical companies export to Turks And Caicos?

4 Indian companies. Largest: PARAM CORPORATION with $31.7K.

How can I find verified Indian pharmaceutical suppliers for Turks And Caicos?

TransData Nexus covers 4 active exporters with shipment history and trade values at transdatanexus.com.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to Turks And Caicos identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 189 verified shipments from 4 Indian exporters to 4 Turks And Caicos buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

4 Exporters

4 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

India to Turks And Caicos Pharmaceutical Export